This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
NOVEMBER 8, 2024
HCPLive spoke to Sadaka at NASPHAN 2024 about the increase in hospital admissions among children with gastroparesis after the COVID-19 pandemic.
92 
HCPLive
MARCH 13, 2024
In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.
115 
HCPLive
JANUARY 1, 2025
Patients hospitalized for severe COVID-19 had an accelerated eGFR decline relative to those with pneumonia due to other infections.
105 
Medical Xpress - Cardiology
JANUARY 24, 2025
With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's critical to pay close attention to your heart and symptomsespecially if you have heart disease or the risk factors for it.
111 
American Heart News - Heart News
NOVEMBER 11, 2024
survival rates from out-of-hospital cardiac arrests fell significantly at the beginning of the COVID-19 pandemic in 2020 and only slightly. This news release contains updated information and data not included in the abstract. Research Highlights: U.S.
100 
HCPLive
FEBRUARY 19, 2024
A new study found non-hospitalized COVID-19 survivors from a Vietnam general population had a 76.1% prevalence of insomnia, with 22.8% of respondents with insomnia scoring for severe insomnia.
72 
HCPLive
JULY 31, 2024
Trust in physicians and hospitals dropped from over 70% in 2020 to under 50% in 2024, with declines seen across all demographics, a new survey shows.
140 
Medical Xpress - Cardiology
NOVEMBER 11, 2024
Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and have continued to remain lower than in the pre-pandemic years of 2015–2019, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.,
75 
Frontiers in Cardiovascular Medicine
MARCH 4, 2024
The aim of the present study was to comprehensively assess symptoms and possible long-term impairments 6 and 18 months after hospitalization for severe COVID-19 infection. Methods This prospective registry included patients with PCR-confirmed COVID-19 infection requiring hospitalization.
64 
Frontiers in Cardiovascular Medicine
DECEMBER 13, 2023
Background & aims Coronavirus disease 2019 (COVID-19) is strongly associated with myocarditis or pericarditis risk in observational studies, however, there are still studies that do not support the above conclusion. Severe COVID-19 was not associated with myocarditis [odds ratio (OR), 1.00; 95% confidence interval (CI), 0.89–1.12;
69 
Frontiers in Cardiovascular Medicine
JANUARY 8, 2024
Background Coronavirus disease (COVID-19)-associated acute pericarditis has recently received much attention owing to its high frequency associated with pericardial tamponade (PT), showing unfavorable prognosis. Conclusions We encountered a unique case of COVID-19-associated acute pericarditis exhibiting hemorrhagic PT.
72 
Med Page Today
JULY 12, 2024
(MedPage Today) -- The angiotensin receptor blocker (ARB) losartan led to hypotension and failed to improve mortality in patients hospitalized for acute COVID-19, according to the randomized, prospective -- and prematurely terminated -- ARBs.
129 
American College of Cardiology
JANUARY 10, 2025
Therapeutic- compared with prophylactic-dose anticoagulation was associated with reduced 28-day mortality in patients hospitalized for COVID-19, according to a prospective meta-analysis from the World Health Organization (WHO) Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group.
51 
Med Page Today
DECEMBER 24, 2024
(MedPage Today) -- Trials evaluating anticoagulation in patients hospitalized for COVID-19 did not consistently favor stepping up dosing for short-term survival, according to a systematic review and prospective meta-analysis. Among 22 studies.
88 
HCPLive
DECEMBER 4, 2024
Dexamethasone treatment was linked to worse clinical outcomes in patients with sickle cell disease hospitalized for COVID-19.
59 
Coronary Artery Disease Journal
OCTOBER 23, 2023
Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. All COVID-19 hospitalizations with age ≥ 18 years were included in the analyses.
52 
Coronary Artery Disease Journal
OCTOBER 31, 2023
Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2% Results There were 1 050 905 hospitalizations with STEMI, and there was an 8.2%
52 
HCPLive
MARCH 1, 2024
In a post hoc analysis of the ACCT-2 study, a risk profile using simple hematologic parameters identified patients hospitalized with COVID-19 who benefited most from baricitinib treatment.
52 
Open Heart
NOVEMBER 20, 2023
Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. to 2.1%, p=0.755) or in-hospital mortality (0.1%, (95% CI) –0.9% Data were fitted to segmented regression models with March 2020 as the breakpoint.
52 
American College of Cardiology
JANUARY 24, 2025
Finally, Dr. Eagle explores anticoagulation for patients who are hospitalized with COVID-19. Eagle looks at left atrial appendage occlusion for stroke prevention in patients with AFib. He then discusses a new treatment for severe hypertrophic cardiomyopathy in children.
53 
Open Heart
JANUARY 27, 2022
Objectives (1) To evaluate the prevalence and hospitalisation rate of COVID-19 infections among patients with dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) in the Royal Brompton and Harefield Hospital Cardiovascular Research Centre (RBHH CRC) Biobank. (2) vs 16.5%, p=0.002).
52 
European Journal of Cardiovascular Nursing
JANUARY 21, 2025
Abstract Aims The COVID-19 pandemic disrupted healthcare systems and possibly impacted the management of heart failure (HF). This study examined the impact of the pandemic on HF hospitalization activities, outcomes, and costs in Victoria, Australia. Further studies using other data (i.e.
40 
SoftCath
OCTOBER 31, 2021
Since the onset of COVID-19, cardiology care has been under extreme risk and adverse complications. For this reason, the management of cardiac patients in the hospital environment has proven to be a real, enormous challenge during and after the pandemic.
52 
Becker's Hospital Review - Cardiology
OCTOBER 17, 2024
The American Heart Association has released a scientific statement providing guidance on the management of patients with COVID-19-related cardiac arrhythmias and autonomic dysfunction. The statement was published Oct. 14 in Circulation.
52 
Journal of Cardiothoracic Surgery
FEBRUARY 14, 2025
Studies show conflicting results regarding the impact of the COVID-19 pandemic on the treatment of patients with coronary artery disease requiring cardiac surgery and data from Germany are lacking. In this stu.
52 
ECG Cases
JANUARY 12, 2021
EM leaders have important voices for speaking on disaster preparation and response in our hospitals, health care systems, and communities. Dr. David Petrie explores COVID-19 pandemic lessons and offers pointers for redesigning a better health care system.
52 
Frontiers in Cardiovascular Medicine
AUGUST 11, 2024
BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. This study aimed to identify the applications of telemedicine for cardiovascular diseases management during the Covid-19 pandemic.MethodsThis scoping study was conducted in 2023.
52 
Becker's Hospital Review - Cardiology
NOVEMBER 27, 2024
A recent study using data from the UK BioBank highlighted the extended risk of major adverse cardiac events in individuals who have recovered from COVID-19.
115 115 
Dr. Prateek Bhatnagar
SEPTEMBER 14, 2020
Prateek Bhatnagar, Director Cardiac Surgery & Chief Cardiology Surgeon at Care Hospital, Banjara Hills, Hyderabad, has successfully operated & discharged India’s first post Covid 19 recovered patient who on 16th July, 2020, underwent a triple bypass surgery under Dr. Bhatnagar & his team of doctors here.
52 
Frontiers in Cardiovascular Medicine
APRIL 16, 2024
However, most research in this area has focused on hospital patients. In this study, an electronic database of outpatients with AF, including patients with a history of COVID-19 infection was analyzed in order to assess the most significant risk factors for complications.
52 
ECG Cases
JUNE 2, 2020
What will happen as hospital services ramp up? COVID-19 is not going away anytime soon. The post WTBS 22 The End of The Beginning: What’s Next for EDs in the COVID-19 Pandemic? The post WTBS 22 The End of The Beginning: What’s Next for EDs in the COVID-19 Pandemic? Will staff get tired of precautions?
52 
Open Heart
MAY 9, 2022
Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.
52 
Open Heart
MARCH 13, 2024
Importance Although cardiac injury is a known complication of COVID-19 infection, there is no established tool to predict cardiac involvement and in-hospital mortality in this patient population. Main outcomes and measures In-hospital mortality. Main outcomes and measures In-hospital mortality. to 1.19, p=0.050).
52 
Med Page Today
NOVEMBER 12, 2024
(MedPage Today) -- Rates of survival after out-of-hospital cardiac arrest (OHCA) have not fully bounced back since the COVID-19 pandemic, according to research disseminated by the American Heart Association (AHA). Meanwhile, the odds of bystander.
89 
Dr. Anish Koka
JANUARY 1, 2023
Myopericarditis is a now a well reported complication associated with Sars-Cov-2 (COVID-19) vaccinations. To add insult to injury, he contracted COVID 2 months after the second episode of pericarditis, but had no recurrence of the symptoms of pericarditis.
52 
HCPLive
JULY 11, 2024
Refusal of hospital-administered birth doses of the hepatitis B vaccine declined in Washington, DC, from 2017-2022 despite pandemic-related disruptions to other childhood vaccines.
64 
Circulation
NOVEMBER 11, 2024
Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel. to 1.07; p = 0.24).
40 
Stroke Journal
FEBRUARY 1, 2024
Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. but there were fewer women in the COVID-CVST group (50% vs 68%,P<0.01).
40 
Open Heart
JANUARY 30, 2025
Methods In this single-centre, prospective cohort study, patients with symptomatic sRV failure completed the Netherlands Organisation for Applied Scientific Research/Academic Hospital Leiden Questionnaire for Adult’s Health-Related Quality of Life (TAAQOL) at baseline and after starting treatment with sacubitril/valsartan.
Stroke Journal
FEBRUARY 1, 2024
Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. to COVID 5.6 (p=0.0006).
40 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
With decreases in stroke admission across Latin America during COVID‐19, it is evident that the pandemic has negatively impacted hospitals’ abilities to manage as many stroke cases as before (Pujol‐Lereis et al., Of the 53 we reached out to, 3 filled out the survey and 4 were interviewed. 2022; Clement et al.,
40 
Circulation
NOVEMBER 11, 2024
Background:It is still not well understood whether cardiac injury observed during acute COVID-19 infection extends after recovery from the initial viral infection. Adult patients were identified by hospitalizations using ICD-10 code U07.1 from March 2020 to October 2021.
40 
Open Heart
FEBRUARY 17, 2025
We aimed to quantify the impact of health system disruptions during the COVID-19 pandemic, on their clinical outcomes and whether these differed by socioeconomic and ethnic subgroups. Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent infections.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America. This is likely due to an increasing focus on COVID‐19 treatment during the pandemic. The most common way to treat these strokes is a mechanical thrombectomy.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content